Translational Development Acquisition Corp. Ordinary Shares (TDAC)
Translational Development Acquisition Corp. (TDAC) is a blank check company formed to identify and acquire a promising business, primarily focusing on opportunities in the healthcare and biotechnology sectors. It aims to facilitate growth and development through a strategic merger or acquisition of innovative companies in the life sciences industry.
Company News
As the close of the first half of 2021 nears, investors have a chance to look at some companies that could have big moves in the second half of 2021. Here is a look at five SPACs to watch in the second half of 2021. Churchill Capital Corp IV: Electric vehicle company Lucid Motors is merging with Churchill Capital Corp IV (NYSE: CCIV) in a deal t...
Lottery.com is building a gambling empire one partnership/acquisition at a time, yet still sporting an incredibly cheap valuation.